Cross Atlantic Partners

investment firm

About

Cross Atlantic Partners (CAP) actively manages private equity funds for investment in developing healthcare and life sciences companies in

Details

Founded date
Jan 1, 1994
Operating Status
Active
Legal Name
Cross Atlantic Partners
Also Known As
CAP
Investor Type
PE,Venture Capital

Cross Atlantic Partners (CAP) actively manages private equity funds for investment in developing healthcare and life sciences companies in the United States. They focus on later-stage private and public companies developing innovative drug discovery tools, devices, and services for human healthcare.

Investments

Number of Investments
Number of Lead Investments
13
2
Cross Atlantic Partners has made 13 investments. Their most recent investment was on Jan 8, 2013, when Labcyte raised $5.30M.
Date Company Name
Round Money Raised Industry Lead Investor
Jan 8, 2013 Labcyte
Series D $5.30M Alternative Medicine
Jun 7, 2010 QuesCom
Series Unknown $2.99M Internet
Oct 14, 2008 Sapphire Digital
Series A $4M Health Care
Series Unknown $2M Software Yes
Mar 28, 2008 Filao
Series Unknown $2M Gaming

Employee Profiles

Number of Employee Profiles
2
Cross Atlantic Partners has 2 current employee profiles, including Executive John L. Cassis
Executive
Executive

Exits

Cross Atlantic Partners has had 7 exits. Cross Atlantic Partners most notable exits include Sapphire Digital ,   Labcyte

Date Company Name Exit Type Industry
Sep 14, 2021 Sapphire Digital M&A Health Care Detail
Jan 30, 2019 Labcyte M&A Alternative Medicine Detail
Oct 3, 2016 GQ Life Sciences M&A Health Care Detail
Jan 21, 2014 Confluent Surgical M&A Health Care Detail
Nov 10, 2011 Medivance M&A Biotechnology Detail